TL;DR
Get workout gear delivered free — and shop member deals
- Fast, free delivery on millions of items
- Access to Prime Big Deal Days deals on October 6–7
- Prime Video, Amazon Music and more included
Marjorie Tingley’s sons disputed a Michigan memory-care facility’s requests to use antipsychotic medication after staff reported repeated physical altercations during her care. The family alleges the facility retaliated by sending her to the emergency room and later issuing an eviction notice; the facility denies the allegations. A negligence claim was dismissed, and the remaining claims are scheduled for trial if mediation fails.
Marjorie Tingley’s sons opposed or questioned antipsychotic medication proposed for their mother at a Michigan memory-care facility, setting off a dispute that included eight emergency-room visits and a 30-day eviction notice, according to records reported by KFF Health News. The family alleges the facility used the hospital transfers in retaliation for disagreements over her care; Vista Grande Villa and its former director deny the allegations, and the surviving claims are headed toward trial if mediation does not resolve them.
In December 2024, Vista Grande Villa told Tingley’s adult sons that their 85-year-old mother posed a serious safety risk. Facility behavior logs documented that on at least 10 days in the prior month, she hit, kicked or elbowed aides assisting with bathing, dressing, toileting or changing her briefs. The facility sought permission to sedate her, and the family and administrators continued to disagree about medication into the new year.
As the dispute continued, administrators called 911 after altercations and Tingley was taken to an emergency department repeatedly, according to ambulance, police, facility and medical records cited by KFF Health News. After four trips, the facility issued a 30-day eviction notice; records show four more hospital visits while her family sought another placement. Tingley died at a different facility in January 2025. Her reported cause of death was plaque buildup in the brain, a hallmark of Alzheimer’s disease.
Her five sons sued Vista Grande and the facility’s director at the time, alleging negligence, emotional distress and wrongful eviction. The complaint also alleges the facility initiated emergency-room trips in retaliation for the family’s objections. A Michigan Circuit Court judge dismissed the negligence claim on legal grounds. The remaining claims are scheduled for trial early next year if mediation fails. Vista Grande’s attorneys and the former director did not respond to KFF Health News’ requests for comment; the facility denied the allegations in court filings.
Medication Disputes Can Threaten Placement
The case highlights a difficult decision families can face when dementia-related behavior creates safety concerns: whether to consent to medication with serious potential risks or resist treatment and risk conflict with a care provider. The dispute also puts the consequences of memory-care placement decisions under scrutiny, since an eviction can require a family to find a new facility for someone with complex needs.
The medications at issue are not risk-free. The Food and Drug Administration requires warnings that antipsychotics increase the risk of death in older people with Alzheimer’s disease and similar conditions. A JAMA study cited by KFF Health News estimated that one in four Medicare beneficiaries with dementia may be inappropriately prescribed antipsychotics or other brain-altering medications that can contribute to delirium, falls and hospitalizations. That estimate describes potentially inappropriate prescribing across the population; it does not establish whether Tingley’s proposed treatment was appropriate.
antipsychotic medication for dementia patients
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
A Long Campaign Against Overprescribing
Antipsychotics are approved by the FDA primarily to treat schizophrenia, but they are also used in care settings when people with dementia show agitation or aggression. Dementia can damage brain areas involved in impulse control and perception. A person may react physically out of fear, fail to recognize a caregiver, or be unable to communicate pain or another unmet need. Those explanations do not remove the safety risks for residents and workers, but they can affect how caregivers interpret and respond to behavior.
Federal concern about the use of tranquilizing drugs in long-term care dates back decades. A 1975 Senate report described prescription-drug misuse in nursing homes. In 2012, the Centers for Medicare & Medicaid Services began its Partnership to Improve Dementia Care, a campaign aimed at reducing antipsychotic overprescribing. KFF Health News reported that, excluding people with schizophrenia, antipsychotics were given to one in seven nursing-home residents in 2025. The report also cited more than five million Medicare beneficiaries diagnosed with dementia.
Vista Grande was a nonprofit when the events occurred. Earlier this year, it became a wholly owned subsidiary of Otterbein SeniorLife and was renamed Otterbein Jackson SeniorLife Community. Otterbein is not named in the lawsuit; representatives did not respond to KFF Health News’ request for comment.
““They just wanted to have her drugged up. It’s a lot easier to take care of someone who’s just out of it.””
— David Tingley, one of Marjorie Tingley’s sons
memory care safety monitoring devices
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Court Has Not Resolved Retaliation Claims
The family’s account that the emergency-room transfers were retaliatory is an allegation, not an established finding. Vista Grande and its former director have denied the allegations, and the facility’s court filing attributes the hospital trips to the family’s refusal to approve treatment on site. The negligence claim has been dismissed, but the remaining claims have not been decided.
The available report does not establish whether antipsychotic medication was ultimately administered to Tingley, what alternatives the facility or family considered in detail, or what each emergency evaluation concluded. It also does not resolve whether any individual hospital transfer was medically necessary or improperly initiated. Those questions may be addressed through the remaining litigation, but no outcome is reported.
dementia patient agitation management tools
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Mediation Could Precede Trial
The parties are expected to attempt mediation. If they do not reach an agreement, the remaining lawsuit claims are scheduled for trial early next year, according to the reported court status. The trial could address the family’s claims of emotional distress and wrongful eviction and its allegation that emergency-room trips were used in retaliation; the outcome remains unknown.
The legal dispute is separate from the broader policy question of how memory-care facilities should respond when residents’ behavior creates safety concerns. The case record and any later court rulings may clarify the events at Vista Grande, but the supplied reporting does not say whether the facility’s new ownership has changed its medication or placement practices.
As an affiliate, we earn on qualifying purchases.
Key Questions
Why did Vista Grande seek medication for Marjorie Tingley?
The facility told her sons she posed a safety risk. Its behavior logs said she hit, kicked or elbowed aides on at least 10 days in one month while they helped with personal care. The facility sought permission to sedate her; the report does not establish which medication, if any, she ultimately received.
What does the family allege in its lawsuit?
The family accuses Vista Grande and its former director of negligence, emotional distress and wrongful eviction. It also alleges the facility sent Tingley to the emergency room in retaliation for disagreements about her care. The facility and former director deny the allegations. A judge dismissed the negligence claim, while the remaining claims are pending.
Are antipsychotics risk-free for older people with dementia?
No. The FDA requires drug companies to warn that antipsychotics increase the risk of death in older people with Alzheimer’s and similar diseases. KFF Health News also cites potential risks including delirium, falls and hospitalizations. The report does not determine whether medication was appropriate in Tingley’s individual circumstances.
When could the remaining claims go to trial?
A trial is scheduled for early next year if mediation fails, according to the court status described by KFF Health News. The supplied report does not give a specific trial date or a final resolution.
Source: rss
Fall Picks
fall essentials
As an affiliate, we earn on qualifying purchases.
